Summary of Product Characteristics
last updated on the eMC:
03/01/2012
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 03/01/2012 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.2 - Posology and method of administration
-
Change to section 10 date of revision of the text
|
|
Updated on 21/07/2009 and displayed until 03/01/2012
|
Reasons for adding or updating:
|
-
Change to section 4.9 - Overdose
|
|
Updated on 11/07/2007 and displayed until 21/07/2009
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contraindications
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 date of revision of the text
|
|
Updated on 19/04/2006 and displayed until 11/07/2007
|
Reasons for adding or updating:
|
-
Change to section 4.8 - Undesirable Effects
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 25/09/2003 and displayed until 19/04/2006
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 25/09/2003 and displayed until 25/09/2003
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 19/09/2003 and displayed until 25/09/2003
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contra-indications
-
Change to section 6.1 - List of Excipients
|
|
Updated on 02/08/2001 and displayed until 19/09/2003
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 06/09/1999 and displayed until 02/08/2001
|
Reasons for adding or updating:
|
|
|
|
